Skip to main content
Clinical Trials/DRKS00010864
DRKS00010864
Recruiting
Phase 2

Cognitive Stimulation in patients with Parkinson's Disease Dementia (Train-ParC-D): Efficacy, prediction of response, and health-economic evaluation. - Train-ParC-D

Medizinische Psychologie | Neuropsychologie und Gender Studies & Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)0 sites82 target enrollmentApril 19, 2017

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
F02.3
Sponsor
Medizinische Psychologie | Neuropsychologie und Gender Studies & Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
Enrollment
82
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2017
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medizinische Psychologie | Neuropsychologie und Gender Studies & Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of idiopathic Parkinson's disease (confirmed by a neurologist or psychiatrist);
  • \- Parkinson's disease dementia according to Level\-I\-Diagnosis of the Movement Disorder Society Task Force (Dubois et al., 2007; Emre et al., 2007\);
  • \- Mild to moderate dementia operationalized with the help of the MMSE (range: 25 to 10 points);
  • \- The patient is able to follow instructions;
  • \- The patient is able to walk at least 10 meters without any help;
  • \- Age: 50 to 85 years;
  • \- German as native language or excellent German speaking skills;
  • \- No/corrected visual or auditory impairments;
  • \- Informed consent of a relative of the patient to complete external ratings of the patient as well as self\-ratings.

Exclusion Criteria

  • \- MMSE score above 25 points or below 10 points;
  • \- Major depression (operationalized with the GDS \> 10 points);
  • \- Acute suicidality;
  • \- Alcohol or drug abuse in the last three years;
  • \- Severe neurological and/or psychiatric diseases with cognitive symptoms (acute or in the past; psychosis, epilepsy, stroke, traumatic brain injury, brain tumor);
  • \- Further severe/life\-threatening comorbidities which constitute an obstacle to the participation in a study.

Outcomes

Primary Outcomes

Not specified

Similar Trials